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Structural MRI changes that are seen in normal 
aging and Alzheimer disease (AD) include atrophy, 
white matter hyperintensities, iron accumulation, mi-
crobleeds and invisible changes. Similar ﬁ ndings oc-
cur with Alzheimer s´ disease and for all lesion type a 
continuum exists between the normal and the disease 
status. Automated measurement methods allow to de-
termine loss of brain volume over time, and important-
ly either visual or automated measurement of atrophy 
of the medial temporal lobe has become a support-
ive feature in the diagnosis of prodromal AD. White 
matter abnormalities are almost ubiquitous in the 
brains of elderly people and patients with Alzheimer s´ 
disease. Microbleeds are less common, but they ap-
pear to be related to white matter changes and both 
types of lesions are considered to represent the radio-
logical correlate of small vessel disease. White matter 
lesions and microbleeds predict cognitive decline in 
normal aging and evidence emerges that the same is 
true in Alzheimer dementia. Th e importance of white 
matter hyperintensities in the aging brain depends 
on the type of abnormalities. Coalescent lesions have 
a malignant course, while punctuate changes in the 
deep white matter and most periventricular lesions 
are benign. Studies examining the regional distribu-
tion of white matter lesions and microbleeds in Al-
zheimer disease suggest a heterogeneous etiology of 
lesions with posterior involvement being suggestive of 
amyloid angiopathy and frontal location suggesting 
arteriolosclerosis. Diﬀ erent location may be linked to 
diﬀ erent clinical outcome, but even more importantly 
in the context of antiamyloid treatment strategies dif-
ferent risk for adverse events such as vasogenic edema 
or bleeding. Th e natural course of small vessel disease 
related brain changes, particularly of cerebral mi-
crobleeds in normal aging and Alzheimer s´ disease is 
widely unknown, but represents a crucial issue when 
using these abnormalities in clinical trials to deter-
mine adverse or beneﬁ cial treatment response. Iron 
accumulates with age in a region-speciﬁ c manner and 
most interestingly ultra-high ﬁ eld magnets allow to 
delineate iron in plaques. Th is methods has thus been 
suggested to represent a way of non-invasive in vivo 
study of cortical amyloid plaque detection. Micro-
structural tissue changes in normal appearing brain 
tissue as seen with diﬀ usion tensor and magnetisation 
transfer imaging play an important role in cognitive 
decline during normal aging, the contribution of such 
tissue alterations in AD are less well explored.
